Welcome to LookChem.com Sign In|Join Free
  • or
D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid, commonly known as voglibose, is a pharmaceutical compound that serves as a medication for the treatment of type 2 diabetes. It is classified under the category of alpha-glucosidase inhibitors, which function by decelerating the digestive process of carbohydrates. This mechanism aids in the moderation of postprandial blood sugar levels and mitigates the likelihood of glucose level spikes. Voglibose is usually ingested prior to meals to facilitate the regulation of blood sugar and is frequently employed in conjunction with other diabetes medications. It is accessible in tablet form and is generally well-tolerated, with minor side effects such as bloating, gas, and diarrhea. In essence, voglibose is a vital component in the management of type 2 diabetes, assisting individuals in maintaining better control over their blood sugar levels.

79276-23-6

Post Buying Request

79276-23-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

79276-23-6 Usage

Uses

Used in Pharmaceutical Industry:
D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid is used as a therapeutic agent for the management of type 2 diabetes. It operates by inhibiting the activity of alpha-glucosidase enzymes, which are responsible for the breakdown of carbohydrates into glucose. This inhibition slows down the rate at which glucose is absorbed into the bloodstream, thereby reducing postprandial hyperglycemia and supporting the overall regulation of blood sugar levels.
Used in Diabetes Management:
D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid is utilized as a diabetes medication to assist in the control of blood sugar levels in individuals with type 2 diabetes. By slowing the digestion of carbohydrates, voglibose helps prevent sudden increases in blood glucose after meals, which is crucial for the daily management of diabetes and for reducing the risk of long-term complications associated with the disease.
Used in Combination Therapy:
D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid is also used in combination with other diabetes medications to enhance the effectiveness of blood sugar control. This combined approach can provide a more comprehensive management strategy for patients with type 2 diabetes, potentially leading to improved glycemic control and better health outcomes.

Check Digit Verification of cas no

The CAS Registry Mumber 79276-23-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,2,7 and 6 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 79276-23:
(7*7)+(6*9)+(5*2)+(4*7)+(3*6)+(2*2)+(1*3)=166
166 % 10 = 6
So 79276-23-6 is a valid CAS Registry Number.

79276-23-6Upstream product

79276-23-6Downstream Products

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 79276-23-6